|Traded as||NYSE: PKI
S&P 500 Component
|Industry||Human health, environmental health|
|Headquarters||Waltham, Massachusetts, U.S.|
|Robert Friel, Chairman, CEO, and President|
|Products||Analytical instruments, lab technology, diagnostics, medical imaging equipment, informatics, cord blood bank|
|Revenue||$2.2 billion USD (2013)|
Number of employees
|Slogan||For the Better|
PerkinElmer, Inc., is an American multinational corporation focused in the business areas of human and environmental health, including: environmental analysis, food and consumer product safety, medical imaging, drug discovery, diagnostics, biotechnology, industrial applications, and life science research. PerkinElmer produces analytical instruments, genetic testing and diagnostic tools, medical imaging components, software, instruments, and consumables for multiple end markets.
PerkinElmer is part of the S&P 500 index and operates in 150 countries.
Perkin-Elmer was founded in 1937 by Richard Perkin and Charles Elmer as an optical design and consulting company. In 1944, Perkin-Elmer entered the analytical-instruments business, and in the early 1990s, partnered with Cetus Corporation (and later Hoffmann-La Roche) to pioneer the polymerase chain reaction (PCR) equipment industry. Analytical-instruments business was also operated from 1954 to 2001 in Germany, by the Bodenseewerk Perkin-Elmer GmbH located in Überlingen at Lake Constance, and England (Perkin Elmer Ltd) at Beaconsfield in Buckinghamshire.
Modern PerkinElmer traces its history back to a merger between divisions of what had been two S&P 500 companies, EG&G Inc. (formerly NYSE: EGG) of Wellesley, Massachusetts and Perkin-Elmer (formerly NYSE: PKN) of Norwalk, Connecticut. On May 28, 1999, the non-government side of EG&G Inc. purchased the Analytical Instruments Division of Perkin-Elmer, its traditional business segment, for US$425 million, also assuming the Perkin-Elmer name and forming the new PerkinElmer company, with new officers and a new Board of Directors. At the time, EG&G made products for diverse industries including automotive, medical, aerospace and photography.
The old Perkin-Elmer Board of Directors and Officers remained at that reorganized company under its new name, PE Corporation. It had been the Life Sciences division of Perkin-Elmer, and its two component tracking stock business groups, Celera Genomics (NYSE: CRA) and PE Biosystems (formerly NYSE: PEB), were centrally involved in the highest profile biotechnology events of the decade, the intense race against the Human Genome Project consortium, which then resulted in the genomics segment of the technology bubble.
In 1992 the company merged with Applied Biosystems. In 1997 they merged with PerSeptive Biosystems. On July 14, 1999 the new analytical instruments maker PerkinElmer cut 350 jobs, or 12%, in its cost reduction reorganization. In 2006 PerkinElmer sold off the Fluid Sciences division for approximately $400M; the aim of the selloff was to increase the strategic focus on its higher-growth health sciences and photonic markets. Following on from the selloff, a number of small businesses were acquired, including Spectral Genomics, Improvision, Evotec-Technologies, Euroscreen, ViaCell and Avalon Instruments. The brand "Evotec-Technologies" remains the property of Evotec, the former owner company. PerkinElmer had a license to use the brand till the end of year 2007.
PerkinElmer has continued to expand its interest in medicine with the acquisitions of clinical laboratories, In July 2006, it acquired NTD Labs located on Long Island, New York. The laboratory specializes in prenatal screening during the first trimester of pregnancy. In October 2007, it purchased ViaCell, Inc. with its offices in Boston and cord blood storage facility in Kentucky near Cincinnati. The company was renamed ViaCord.
In March 2008, PerkinElmer purchased Pediatrix Screening (formerly Neo Gen Screening), a laboratory located in Bridgeville, PA specializing in screening newborns for various inborn errors of metabolism such as phenylketonuria, hypothyroidism, and sickle-cell disease. It renamed the laboratory PerkinElmer Genetics, Inc.
In May 2011, PerkinElmer announced the signature of an agreement to acquire CambridgeSoft, and the successful acquisition of ArtusLabs.
Hubble optics project
Perkin-Elmer's Danbury Optical System unit was commissioned to build the optical components of the Hubble Space Telescope. The construction of the main mirror began in 1979 and completed in 1981. The polishing process ran over budget and behind schedule, producing significant friction with NASA. Due to a miscalibrated null corrector, the primary mirror was also found to have a significant spherical aberration after reaching orbit on STS-31. Perkin-Elmer's own calculations and measurements revealed the primary mirror's surface discrepancies, but the company chose to withhold that data from NASA. A NASA investigation heavily criticized Perkin-Elmer for management failings, disregarding written quality guidelines, and ignoring test data that revealed the miscalibration. Corrective optics were installed on the telescope during the first Hubble service and repair mission STS-61. The correction, COSTAR, was applied entirely to the secondary mirror and replaced existing instrumentation; the aberration of the primary mirror remained uncorrected.
The company agreed to pay US $15 million, essentially forgoing its fees in polishing the mirror, to avoid a threatened liability lawsuit under the False Claims Act by the Federal government. Hughes Aircraft which acquired the Danbury Optical System unit one month after the launch of the telescope, paid $10 million. The Justice Department asserted that the companies should have known about the flawed testing. Trade group Aerospace Industries Association protested when concerns were raised in the aerospace industry that aerospace companies might be held liabile for failed equipment.
In the 1950s, an aerial panoramic camera lens was capable of recording the entire state of Pennsylvania in two flyovers, with resolution that enabled one to count the autos on the Pennsylvania Turnpike.
- Cellular research
- Clinical genetics & diagnostics
- Drug discovery
- Environmental Analysis - Air, water, and soil testing and analysis
- Food, Flavors & Agricultural Analysis - Food safety
- Forensic analysis
- Hydrocarbon processing
- Life science research
- Lubricants and oils
- Imaging, lighting, sensors
- Pharmaceutical development and manufacturing
- Semiconductors and electronics
- Renewable Energy - Analysis and testing for biofuels, solar, and wind energy
- Global Multivendor Laboratory Maintenance & Repair Services
- Global Laboratory Relocation Services
- What is the logic of biology? A letter from Tony White to our shareholders, PE Corporation, 1999 Annual Report, CEO letter
- COMPANY NEWS; PERKIN-ELMER CUTS 12% OF WORK FORCE, New York Times, Published: July 15, 1999
- PerkinElmer. "PerkinElmer Signs Agreement to Acquire CambridgeSoft Corporation and Completes Purchase of ArtusLabs, Inc.". Retrieved 2011-05-20.
- Reuters (September 8, 2011). "PerkinElmer to buy Caliper for $600 mln". Retrieved 2011-09-08.
- VARTABEDIAN, RALPH (13 October 1993). "Hughes, Perkin-Elmer to Pay U.S. for Hubble Telescope Flaw". Retrieved 20 April 2015.
- PDF (5.62 MiB), 1990, Lew Allen, Chairman, NASA Technical Report NASA-TM-103443. The spacing of the field lens in the corrector was to have been done by laser measurements off the end of an invar bar. Instead of illuminating the end of the bar, however, the laser in fact was reflected from a worn spot on a black-anodized metal cap placed over the end of the bar to isolate its center (visible through a hole in the cap). The technician who performed the test noted an unexpected gap between the field lens and its supporting structure in the corrector and filled it in with an ordinary metal washer. (No longer available prior to 10/09)
- O'Neill (Associated Press), Helen (December 25, 2011). "Decades later, a Cold War secret is revealed". The Virginian-Pilot. Retrieved December 25, 2011.
- "Perkin Elmer, Our History". 2012. Retrieved 8 Apr 2014.